Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Predicting Psoriatic Arthritis in Early Psoriasis
1
Mins
July 2025
Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce treatment…
Read more
1
Mins
24 Jul 2025
Predicting Psoriatic Arthritis in Early Psoriasis
Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce treatment…
1
Mins
24 Jul 2025
Long-Term Selexipag for Digital Ulcers in Systemic Sclerosis
Digital ulcers (DU) affect approximately 50% of patients with systemic sclerosis (SSc), causing significant pain and…
2
Mins
24 Jul 2025
Dual JAK/ROCK inhibition in Rheumatoid Arthritis
Despite various treatments, the first-line approach for rheumatoid arthritis (RA) has long relied on disease-modifying antirheumatic…
1
Mins
24 Jul 2025
Cancer Risk in Rheumatoid Arthritis: Insights from BIOBADASER III
Safety data on the use of biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) in patients…
2
Mins
24 Jul 2025
Glucocorticoid-Induced Osteoporosis: Comparing Sequential and Single-Agent Therapies
Eleven patients were assigned to the ROMO-DMAb group, 14 to the DMAb group, and 14 to the BP group. The median age of all…
2
Mins
24 Jul 2025
Novel Imaging of Spinal Lesions in Axial and Peripheral Arthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that can lead to irreversible structural damage…
1
Mins
24 Jul 2025
Norwegian Data on Birth Factors and Juvenile Idiopathic Arthritis Risk
Most studies on juvenile idiopathic arthritis (JIA) aetiology are case-control studies, which are susceptible to recall and selection bias…
2
Mins
24 Jul 2025
IFN-Stimulated Genes Mark Preclinical Synovitis in Anti-CCP+ Individuals
In individuals who are anti-citrullinated peptide positive (anti-CCP+) at risk of developing rheumatoid arthritis (RA), ultrasound…
Loading posts...
1
2
3
…
7
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View